Almac's North Carolina Facility Doubles Capacity
Almac’s North Carolina Facility Doubles Capacity
Almac Clinical Services' site in Durham, N.C., recently doubled its capacity and is a licensed pharmacy. In addition, it successfully passed an FDA inspection earlier this year. The Durham facility was part of the Duke Clinical Research Institute from 1990 to 2000 and provided clinical pharmacy, packaging, distribution and supply chain services, which it continues to do as Almac. The division has seen continued growth from clients operating in the not- for-profit sector on academically based clinical trials.
The unit's staff is experienced with the academically-based trials and has understanding of the full clinical trial process, including disease state knowledge, how patients move through the hospital and pharmacy best practice when working directly with investigators. Project leaders are also involved with writing the CTM section of the clinical protocol through to reconciling drug returned from the clinical sites at close out.
Donna Christopher, VP of Operations at Almac Clinical Services, Durham Facility commented, "As our business continues to evolve under the Almac brand we have stayed close to our roots in academically based clinical trials - an area where our expertise lies. Alongside our core contract services, we also advise many of our clients on how to conduct their trials. From the outset we provide information on clinical input, study materials required, efficient drug kits design as well as full supply chain management in addition to providing training and monitoring to sites. We work together with our Academic clients to ensure their clinical trials are run to maximum efficiency enabling them to focus solely on their trial results. In recent months we have doubled our capacity to enable us to meet the increased demands for our services.”
If you would like more information on the services we provide or are an Academic Institution looking for a partner to manage your clinical trial please visit: http://www.almacgroup.com/clinicalservices/academic-clinical-trials.aspx
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
